JP2025011142A5 - - Google Patents
Info
- Publication number
- JP2025011142A5 JP2025011142A5 JP2024168470A JP2024168470A JP2025011142A5 JP 2025011142 A5 JP2025011142 A5 JP 2025011142A5 JP 2024168470 A JP2024168470 A JP 2024168470A JP 2024168470 A JP2024168470 A JP 2024168470A JP 2025011142 A5 JP2025011142 A5 JP 2025011142A5
- Authority
- JP
- Japan
- Prior art keywords
- application
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862773885P | 2018-11-30 | 2018-11-30 | |
| US62/773,885 | 2018-11-30 | ||
| US201962826462P | 2019-03-29 | 2019-03-29 | |
| US62/826,462 | 2019-03-29 | ||
| PCT/US2019/064032 WO2020113224A2 (en) | 2018-11-30 | 2019-12-02 | Chimeric antigen receptor factories and methods of use thereof |
| JP2021530875A JP7649239B2 (ja) | 2018-11-30 | 2019-12-02 | キメラ抗原受容体ファクトリおよびその使用方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530875A Division JP7649239B2 (ja) | 2018-11-30 | 2019-12-02 | キメラ抗原受容体ファクトリおよびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025011142A JP2025011142A (ja) | 2025-01-23 |
| JP2025011142A5 true JP2025011142A5 (enExample) | 2025-10-15 |
Family
ID=70853578
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530875A Active JP7649239B2 (ja) | 2018-11-30 | 2019-12-02 | キメラ抗原受容体ファクトリおよびその使用方法 |
| JP2024168470A Pending JP2025011142A (ja) | 2018-11-30 | 2024-09-27 | キメラ抗原受容体ファクトリおよびその使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530875A Active JP7649239B2 (ja) | 2018-11-30 | 2019-12-02 | キメラ抗原受容体ファクトリおよびその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220047634A1 (enExample) |
| EP (1) | EP3887509A4 (enExample) |
| JP (2) | JP7649239B2 (enExample) |
| KR (1) | KR20210135475A (enExample) |
| AU (1) | AU2019387566A1 (enExample) |
| CA (1) | CA3119644A1 (enExample) |
| WO (1) | WO2020113224A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120795163A (zh) * | 2016-10-14 | 2025-10-17 | 丹娜法伯癌症研究所公司 | 模块化四聚体双特异性抗体平台 |
| CN109401969B (zh) * | 2018-12-13 | 2024-02-02 | 珠海西格膜生物技术有限公司 | 一种细胞工厂的管道连接系统及其使用方法 |
| AU2020290971A1 (en) * | 2019-06-14 | 2021-12-23 | Dana-Farber Cancer Institute, Inc. | Antibodies against PD-1 and methods of use thereof |
| CA3141927A1 (en) * | 2019-06-14 | 2020-12-17 | Dana-Farber Cancer Institute, Inc. | Antibodies against pd-1 and methods of use thereof |
| US20230399412A1 (en) * | 2020-10-12 | 2023-12-14 | Nanjing IASO Biotechnology Co., Ltd. | Antibody and chimeric antigen receptor (car) binding to cd70, and application thereof |
| TW202237827A (zh) | 2020-12-03 | 2022-10-01 | 美商世紀治療股份有限公司 | 經基因工程改造之細胞及其用途 |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| WO2022133169A1 (en) | 2020-12-18 | 2022-06-23 | Century Therapeutics, Inc. | Chimeric antigen receptor systems with adaptable receptor specificity |
| CN114565761B (zh) * | 2022-02-25 | 2023-01-17 | 无锡市第二人民医院 | 一种基于深度学习的肾透明细胞癌病理图像肿瘤区域的分割方法 |
| CN119584995A (zh) * | 2022-06-09 | 2025-03-07 | 泰利斯制药(创新)有限公司 | 组合疗法 |
| US12257304B2 (en) | 2023-03-03 | 2025-03-25 | Arsenal Biosciences, Inc. | Systems targeting PSMA and CA9 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011139375A1 (en) * | 2010-05-06 | 2011-11-10 | Ludwig Institute For Cancer Research Ltd | Antibodies directed against carbonic anhydrase ix and methods and uses thereof |
| CA2828753C (en) * | 2011-03-16 | 2022-07-26 | arGEN-X BV | Antibodies to cd70 |
| EP2814846B1 (en) * | 2012-02-13 | 2020-01-08 | Seattle Children's Hospital d/b/a Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| US20180334490A1 (en) * | 2014-12-03 | 2018-11-22 | Qilong H. Wu | Methods for b cell preconditioning in car therapy |
| US10870705B2 (en) * | 2014-12-19 | 2020-12-22 | Dana-Farber Cancer Institute, Inc. | Chimeric antigen receptors specific for carbonic acid anhydrase IX |
| WO2016149578A1 (en) * | 2015-03-19 | 2016-09-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dual specific anti-cd22-anti-cd19 chimeric antigen receptors |
| US20190031759A1 (en) * | 2015-04-30 | 2019-01-31 | Technion Research & Development Foundation Limited | Chimeric antigen receptors and methods of their use |
| MX2018005315A (es) | 2015-10-30 | 2018-08-14 | Aleta Biotherapeutics Inc | Composiciones y metodos para el tratamiento del cancer. |
| ES2900233T3 (es) | 2017-02-14 | 2022-03-16 | Kite Pharma Inc | Moléculas que se unen a CD70 y métodos de uso de las mismas |
| EP3585817A4 (en) | 2017-02-22 | 2020-12-02 | Aleta Biotherapeutics Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER |
-
2019
- 2019-01-12 US US17/298,271 patent/US20220047634A1/en active Pending
- 2019-12-02 WO PCT/US2019/064032 patent/WO2020113224A2/en not_active Ceased
- 2019-12-02 CA CA3119644A patent/CA3119644A1/en active Pending
- 2019-12-02 KR KR1020217019851A patent/KR20210135475A/ko active Pending
- 2019-12-02 AU AU2019387566A patent/AU2019387566A1/en active Pending
- 2019-12-02 JP JP2021530875A patent/JP7649239B2/ja active Active
- 2019-12-02 EP EP19889550.0A patent/EP3887509A4/en active Pending
-
2024
- 2024-09-27 JP JP2024168470A patent/JP2025011142A/ja active Pending